Tender detail
Rebate agreement for medicines containing denosumab
Summary
The tender concerns the conclusion of non-exclusive rebate agreements for medicines containing denosumab for the period 01/07/2026 to 30/06/2028, with an option to extend the contract once by 12 months. Bidders are pharmaceutical companies that must identify the medicines listed in the contract annex and note that the agreement ends automatically when a new exclusive contract enters into force.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.